Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
DIAGNOSTIC TEST DESIGNED FOR QUICK LACQUANTIFICATION OF HUMAN HIV-1 TYPE (HIV-1) IN PLASMAHUMAN FROM PERSONS INFECTED WITH HIV-1 ON THE INTERVAL OF 40 TO 10,000,000COPIAS / ML, AND IS VALIDATED FOR ALL THE SUBTHPOSES OF A, B, C, D, AE, F, G, H, AB, AG, JYK OF GROUP MY OF THE GROUPS NY O.